Latest APLS reports update at 2024-05-07: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1
  1. Home
  2. Stock quotes
  3. Apellis Pharmaceuticals
  4. Financial Ratios
  5. EV/EBITDA Ratio
Apellis Pharmaceuticals logo
Apellis Pharmaceuticals APLS
$ 42.52 0.52%
mail-toReport an Error

Apellis Pharmaceuticals EV/EBITDA Ratio 2011-2024 | APLS

Annual EV/EBITDA Ratio Apellis Pharmaceuticals

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-6.39 -14.7 -8.25 -4.71 -2.05 - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-2.05 -14.7 -7.21